Health Condition 1: K00-K95- Diseases of the digestive system
Conditions
Interventions
Intervention1: QDEE-Indigestion: Pro digestive MDT will help relieve the digestive complaints. It is recommended in people having symptoms like, loss of appetite, bloating, belching, abdominal discomf
Sponsors
The Himalaya Drug Company
Eligibility
Inclusion criteria
Inclusion criteria: Adult male and female subjects aged >=18 years presenting with either one or more of the following indigestion symptoms like Loss of appetite, nausea, bloating, belching, abdominal discomfort, flatulence. Subjects who are willing to withdraw from any other medication taken for indigestion. Subjects willing to sign informed consent and follow the study procedure. Subjects who has not participated in any similar kind of clinical study in the last one month.
Exclusion criteria
Exclusion criteria: Patients who took any other medications to relieve these symptoms within 2 weeks. Subjects with cardiac, neurological, renal or hepatic dysfunction. A known history or present condition of allergic response to products its components or to any of the ingredients in the test product. Pre-existing systemic disease requiring long-term medications. Pregnant & breast-feeding women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢ To clinically evaluate â??HODT101510Aâ?? in reducing the symptoms of indigestion in subjects with Loss of appetite, nausea, bloating, belching, abdominal discomfort, flatulence etc.Timepoint: The whole study duration is for 4 days with follow up visit at day 1, day 3 and day 5 | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ To assess the incidence of adverse events during the study period and overall compliance to the study intervention.Timepoint: The whole study duration is for 4 days with follow up visit at day 1, day 3 and day 5 | — |
Countries
India
Contacts
Public ContactDr Palaniyamma
The Himalaya Drug Company
Outcome results
None listed